
Organon (OGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
OGN is down 0.07% today. Volume is 1.55M vs a 30-day average of 2.22M (0.70x).
Organon & Co. is scheduled to report earnings Mon, Nov 9, 2026. Analysts expect EPS of $0.94 on revenue of about $1.58B. Stocks often move sharply on earnings day.

Organon (OGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

JERSEY CITY, N.J., October 19, 2026--Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, plans …
Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, today announced that Sebela Women’s Health …

Recently, Zacks.com users have been paying close attention to Organon (OGN). This makes it worthwhile to examine what the stock has in store.